Healthcare provider profile · identity verified

Mohit Anand, MD

Internal Medicine · LOCUST GROVE, VA · NPI 1912976077

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	523	152
Metformin Hcl	Metformin Hcl	358	101
Lisinopril	Lisinopril	333	92
Amlodipine Besylate	Amlodipine Besylate	328	100
Rosuvastatin Calcium	Rosuvastatin Calcium	322	97
Levothyroxine Sodium	Levothyroxine Sodium	283	85
Simvastatin	Simvastatin	224	66
Losartan Potassium	Losartan Potassium	189	58
Omeprazole	Omeprazole	186	60
Albuterol Sulfate Hfa	Albuterol Sulfate	179	46
Alprazolam	Alprazolam	178	25
Carvedilol	Carvedilol	168	52
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	158	47
Pantoprazole Sodium	Pantoprazole Sodium	150	46
Tamsulosin Hcl	Tamsulosin Hcl	149	48
Hydrochlorothiazide	Hydrochlorothiazide	135	44
Gabapentin	Gabapentin	125	28
Metoprolol Succinate	Metoprolol Succinate	117	41
Montelukast Sodium	Montelukast Sodium	112	32
Sertraline Hcl	Sertraline Hcl	104	29
Allopurinol	Allopurinol	96	28
Zolpidem Tartrate	Zolpidem Tartrate	89	14
Metoprolol Tartrate	Metoprolol Tartrate	85	26
Bupropion Xl	Bupropion Hcl	79	23
Eliquis	Apixaban	78	15
Pravastatin Sodium	Pravastatin Sodium	78	25
Clopidogrel	Clopidogrel Bisulfate	71	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	65	44
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	17
Diclofenac Sodium	Diclofenac Sodium	63	20
Furosemide	Furosemide	60	24
Trazodone Hcl	Trazodone Hcl	58	16
Escitalopram Oxalate	Escitalopram Oxalate	54	17
Glimepiride	Glimepiride	54	16
Synthroid	Levothyroxine Sodium	53	17
Celecoxib	Celecoxib	50	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	26
Ezetimibe	Ezetimibe	49	14
Ibuprofen	Ibuprofen	49	14
Potassium Chloride	Potassium Chloride	48	22
Tramadol Hcl	Tramadol Hcl	45	14
Alendronate Sodium	Alendronate Sodium	44	17
Ozempic	Semaglutide	44	suppressed
Fluticasone Propionate	Fluticasone Propionate	43	17
Fenofibrate	Fenofibrate	39	11
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Glipizide	Glipizide	38	12
Colchicine	Colchicine	37	11
Diazepam	Diazepam	37	suppressed
Finasteride	Finasteride	37	13
Atenolol	Atenolol	35	11
Meloxicam	Meloxicam	35	14
Valsartan	Valsartan	35	11
Fenofibrate	Fenofibrate Nanocrystallized	34	11
Nystatin	Nystatin	34	12
Prednisone	Prednisone	34	21
Ipratropium Bromide	Ipratropium Bromide	33	12
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Jardiance	Empagliflozin	30	12
Metformin Hcl Er	Metformin Hcl	30	11
Eszopiclone	Eszopiclone	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Butorphanol Tartrate	Butorphanol Tartrate	28	suppressed
Famotidine	Famotidine	28	13
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Cephalexin	Cephalexin	27	18
Novolog Flexpen	Insulin Aspart	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Methylprednisolone	Methylprednisolone	26	19
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	20
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	11
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Glyburide	Glyburide	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Azithromycin	Azithromycin	15	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Methimazole	Methimazole	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error